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Comparing different analysis methods for
quantifying the MRI amide proton transfer
(APT) effect in hyperacute stroke patients
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F. Sheerine, M. Cellerinie, P. Jezzardd, J. Kennedyc, S. J. Paynea
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Amide proton transfer (APT) imaging is a pH mapping method based on the chemical exchange saturation transfer
phenomenon that has potential for penumbra identiﬁcation following stroke. The majority of the literature thus far
has focused on generating pH-weighted contrast using magnetization transfer ratio asymmetry analysis instead of
quantitative pH mapping. In this study, the widely used asymmetry analysis and a model-based analysis were both
assessed on APT data collected from healthy subjects (n = 2) and hyperacute stroke patients (n = 6, median imaging
time after onset = 2 hours 59 minutes). It was found that the model-based approach was able to quantify the APT
effect with the lowest variation in grey and white matter (≤ 13.8 %) and the smallest average contrast between these
two tissue types (3.48 %) in the healthy volunteers. The model-based approach also performed quantitatively better
than the other measures in the hyperacute stroke patient APT data, where the quantiﬁed APT effect in the infarct
core was consistently lower than in the contralateral normal appearing tissue for all the patients recruited, with
the group average of the quantiﬁed APT effect being 1.5 ± 0.3 % (infarct core) and 1.9 ± 0.4 % (contralateral). Based
on the ﬁtted parameters from the model-based analysis and a previously published pH and amide proton exchange
rate relationship, quantitative pH maps for hyperacute stroke patients were generated, for the ﬁrst time, using APT
imaging. © 2014 The Authors. NMR in Biomedicine published by John Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
Keywords: Amide proton transfer (APT) imaging; chemical exchange saturation transfer (CEST) imaging; magnetization
transfer (MT) imaging; pH; MRI; stroke
INTRODUCTION
The goal of deﬁning the ischaemic penumbra in human
acute ischaemic stroke using imaging that can be widely
used in clinical practice has proved elusive. Much effort
has focused on the imaging of regional cerebral blood ﬂow,
but this has not reliably identiﬁed individuals who might
beneﬁt from targeted intervention, such as endovascular
treatment (1). The original description of the penumbra
suggested that imaging should also capture a measure of
tissue metabolism (2). The measurement of intracellular
pH is an attractive marker for understanding tissue
metabolic stress, given that tissue pH is maintained until
immediately prior to irreversible cerebral infarction (2,3).
Therefore, pH-weighted imaging offers the possibility of
targeting intervention at a stage at which there may be
reversibility of ultimate tissue outcome, although the
reliable use of this technique in this population has been
challenging (4).
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Intracellular pH can be estimated by the quantiﬁcation of am-
ide proton transfer (APT) using the chemical exchange saturation
transfer phenomenon (5), which measures the transfer of pro-
tons between the amide groups on metabolites and proteins
with water; this process is base-catalysed in the physiological
pH range (pH 6.5–7.5) and hence is pH dependent. The estima-
tion of intracellular pH through APT imaging has been demon-
strated in preclinical models (5,6). A previous study has shown
that the quantiﬁed APT effect in the preclinical models is highly
correlated with the ﬁnal infarct tissue area deﬁned using T2
hyperintensity at 24 h (7), suggesting that thresholds may exist
to deﬁne tissue outcome following ischaemic stroke. It is
generally agreed that the APT effect decreases in the infarcted
and salvageable tissue during the hyperacute period, owing to
pH reduction (5,8,9).
APT imaging in patients with ischaemic stroke has been re-
ported (4,10). Despite the potential of APT imaging to measure
pH, most of the literature so far has focused on the generation
of pH-weighted contrast rather than quantitative pH maps. The
most commonly used metric to measure pH-weighted saturation
transfer images is magnetisation transfer ratio asymmetry
(MTRasym) at offsets of ±3.5 ppm relative to water (11–14). How-
ever, this metric is dependent on experimental parameters, such
as power and duration of saturation (15), and contaminated by
various other effects (12,14,16), such as direct water saturation,
conventional magnetisation transfer contrast (MTC), other
metabolites which resonate near amide protons and nuclear
Overhauser enhancement (NOE), which span across a range of
negative frequency offsets from water. Furthermore, NOE has re-
cently been shown to be pH sensitive under low-power satura-
tion (17), making the use of the signal measured at 3.5 ppm
less suitable as a reference for APT quantiﬁcation.
The purpose of this study was to compare the sensitivity of
quantitative Bayesian model-based analysis (18) and conven-
tional approaches, such as MTRasym, to APT data. Two groups of
subjects (healthy volunteers and hyperacute stroke patients
presenting within 6 h of onset) were scanned to establish the
most suitable APT quantiﬁcation method. This was deﬁned as
the analysis method that produced the smallest coefﬁcient of
variation (CV) in healthy tissue and the greatest contrast varia-
tion between infarct core and normal tissue in the acute stroke
patients. In addition, the absolute intracellular pH was calculated
from APT measurements to test the stability of the experimen-
tally derived models in clinical patients.
THEORY
Asymmetry analysis
In an APT imaging experiment, saturation is usually performed
across a range of frequency offsets and the measured saturated
signal plotted against offset is commonly referred to as the z-
spectrum. The APT effect is often calculated, following the prac-
tice in magnetisation transfer (MT) imaging, using MTRasym:
MTRasym ¼ M Δωð Þ M þΔωð ÞM0 [1]
whereM(±Δω) refers to themeasured saturated signal at ±3.5 ppm
andM0 is themeasured unsaturated signal. This analysis inherently
assumes that all the non-APT effects, such as direct saturation, and
MTC effects are symmetric about the water centre frequency; thus,
the pure APT effect can be obtained by taking the difference
between the signals measured at positive and negative offsets.
Various other forms of asymmetry measure, based on the con-
cept of Equation [1], have been studied using phantoms, paramag-
netic chemical exchange saturation transfer agents and animal
models, and it has been found that a complementary approach,
denoted as STcom, where ST stands for saturation transfer, is more
suitable for in vivo applications (19). For consistency in this work,
STcom is renamed as MTRasym_comp, and can be calculated using
the following equation:
MTRasymcomp ¼
M Δωð Þ M þΔωð Þ
M0 M Δωð Þ [2]
Recent studies have shown that the symmetric assumption
does not hold, especially in vivo, because of inherent
asymmetries in MTC or contributions from NOE (12,16,17,20).
Hence, the quantiﬁcation of the APT effect using MTRasym con-
tains not only the APT effect (APT ratio, APTR), but also contribu-
tions from other transfer of magnetisation effects (MTR’asym):
MTRasym ¼ MTR′asym þ APTR [3]
As a result of the contributions from MTR’asym, quantiﬁcation
of the APT effect using the above metric often results in a nega-
tive amplitude when a low saturation power is used, which
would not be expected from a symmetric z-spectrum (18,21);
thus, these metrics are usually regarded as producing APT- or
pH-weighted images. Although the complementary approach
[Equation [2]] is claimed to perform better than the conventional
metric in a biological environment, it still suffers from the same
confounding factors in the negative frequency offsets.
Model-based analysis
In order to quantify the pure APT effect, a model-based ap-
proach has been proposed (18,22–24), in which the full modiﬁed
Bloch equations (25,26) are ﬁtted to the measured data, includ-
ing pools for water, amide and asymmetric MTC effects. Using
the ﬁtted parameters from the model-based analysis, a further
quantitative metric can be calculated, denoted as APTR*. This
measure uses the parameters from the model ﬁtting to generate
an ideal two-pool, water and amide (w+ a), z-spectrum and to
compare it with an ideal one-pool model of water (w) to obtain
the pure APT effect (18,24):
APTR ¼ Sw Δωð Þ  Swþa Δωð Þ
M0
[4]
where S(Δω) is the simulated signal at 3.5 ppm using the ﬁtted
parameters and the subscripts ‘w’ and ‘w+a’ refer to ﬁtted pa-
rameters from the water pool and both the water and amide
pools, respectively. Although a greater number of pools can be
used to perform the model ﬁtting as required, and thus to cor-
rect for asymmetries in the z-spectrum, only the ﬁtted model pa-
rameters of water and amide pools are used here to calculate
APTR*. In principle, APTR* provides a single quantitative measure
of the APT effect (combining both amide proton exchange rate
and concentration contributions) without B0 inhomogeneity,
direct saturation, MTC and NOE inﬂuences, as the latter effects
(MTC and NOE) can be accounted for by grouping them as a sep-
arate pool in the model ﬁtting (18,27).
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MATERIALS AND METHODS
Subject recruitment
Patients with acute stroke were recruited following informed
consent or agreement from a representative according to a
research protocol agreed by the UK National Research Ethics
Service Committee South Central (ref: 12/SC/0292). The data
presented in this study were acquired from the ﬁrst six patients
recruited with lesions greater than 2 cm in diameter on diffu-
sion-weighted imaging (DWI) and without signiﬁcant artefact.
The median age of the studied patients with acute stroke was
83 years. The median onset of symptoms to research MRI scan
was 2 h 59min (range from 1 h 43min to 5 h 46min). Three pa-
tients received intravenous tissue plasminogen activator during
the MRI scan. Two healthy male volunteers (28 and 36 years)
were also scanned to act as controls.
MRI experiment
All MRI scans were performed using a 3 T Siemens Verio scanner
(Siemens Medical Solutions, Erlangen, Germany) in the Oxford
Acute Vascular Imaging Centre located at the John Radcliffe Hos-
pital, Oxford, UK. The following MRI sequences were acquired
from the patients with hyperacute stroke: T1 structural image
with a spatial resolution of 1.781 × 1.781 × 1mm3; DWI with three
directions (b= 0 and 1000 s/mm2); and single-slice APT imaging
with a spatial resolution of 3.4 × 3.4 × 5mm3, where the plane
was selected by an attending clinician based on the lesion seen
on the DWI scan. The APT saturation was performed with 50
Gaussian pulses; each pulse had a ﬂip angle of 184° and duration
of 20ms with 20 ms spacing, to achieve an equivalent continuous
saturation B1 value of 0.55μT (average power) for 2 s. Crusher
gradients were applied between pulses to spoil the residual
transverse magnetisation. A spin-echo echo planar imaging
readout (TR = 5 s, TE = 23 ms, matrix 64x64 and 6/8 partial
Fourier) was performed after all the Gaussian pulses had been
applied. Data were acquired for a range of saturation frequency
offsets; the offsets were evenly distributed from 4.5 to
4.5 ppm with a 0.3 ppm interval for Patients 1 and 2, and the un-
saturated data were acquired with no radiofrequency saturation;
the rest had offsets at 50, 30, 4.1, 3.8, 3.5, 3.2, 2.9,
0.9, 0.6, 0.3, 0, 0.3, 0.6, 0.9, 2.9, 3.1, 3.2, 3.3, 3.4, 3.4, 3.5,
3.5, 3.6, 3.6, 3.7, 3.8, 3.9, 4.1, 30, 50 and ±300 ppm (treated as
unsaturated images). Both sampling schedules acquired 32 APT
images in approximately 3min. For the healthy subjects, only
the T1 structural and APT scans were acquired.
Data processing and analysis
The Brain Extraction Tool in the FSL package (28) was used to re-
move the skull and non-brain areas in all the collected data. All
the imaging modalities were transferred to the T1 space using
FMRIB’s Linear Image Registration Tool (FLIRT) in the FSL pack-
age (29). Rigid body registration with six degrees of freedom
and correlation ratio cost function was applied to register each
imaging modality to T1, except for the single-slice APT data.
For the APT data, the different frequency offset brain images
were ﬁrst aligned to the unsaturated APT brain image using
two-dimensional rigid body registration with three degrees of
freedom. A three-pool model consisting of water (w), amide (a)
and conventional magnetisation transfer contrast + nuclear
Overhauser enhancement (MTC + NOE), following ref. (18), was
then ﬁtted pixelwise to the motion-corrected z-spectrum using
a Bayesian algorithm (30) (www.fmrib.ox.ac.uk/fsl/baycest), with
the prior values of each parameter given in Table 1 and treating
the pulsed saturation as its continuous approximation using av-
erage power (23).
The shift in the z-spectrum caused by B0 inhomogeneity was
corrected pixelwise using the ﬁtted water centre frequency from
the model ﬁtting. MTRasym was obtained by ﬁnding the area
under the curve from 3.3 to 3.7 ppm according to Equation [1]
using the shift-corrected z-spectrum at each pixel; likewise
MTRasym_comp was calculated following Equation [2], where M0
became the unsaturated signal multiplied by the frequency
range considered (3.7 - 3.3 ppm=0.4 ppm).
Table 1. Model parameters with prior values expressed as the mean and standard deviation of a normal distribution, modiﬁed
from ref. (18)
Water pool Amide pool MTC+NOE pool
Parametera Mean SD Mean SD Mean SD
M0 0 10
6 – – – –
M0
i/M0
w – – 0.09/112b 0.02/112b 0 0.01
ln(ki–w) – – 3.0 1.0
c 3.4 1.0
T1 (s) 1.3 0.15 0.77 0.15 1.0 0.15
T2 (ms) 70 14 10 2 0.2 0.04
ω (ppm) 0 0.1 3.5 0.1 2.41 0.1
aM0, initial magnetisation; k, exchange rate; T1, longitudinal relaxation time; T2, transverse relaxation time; ω, chemical shift of each
pool with respect to water; i, amide or conventional magnetisation transfer contrast + nuclear Overhauser enhancement
(MTC+NOE) pool.
bThe mean of the in vivo amide concentration was set as 90mM so that a standard deviation of 20mM would include the reported
values in the literature, 72mM (5) and 100 ± 8mM (20), where 112 M is the concentration of water protons. In the APTR* versus pH
simulations, the amide concentration was assumed to be 100mM instead of 72mM because the latter was estimated without
corrections to various possible contaminations.
cThe mean of the amide proton exchange rate was set to be 20Hz and a natural logarithm was used to make the model parameter
closer to linear to facilitate convergence of the algorithm.
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Previously, a relationship between the base-catalysed amide
proton exchange rate, kaw, and intracellular pH has been cali-
brated using both phosphorus and water exchange spectros-
copy (5), where:
pH ¼ 6:4þ log10
kaw
5:57
 
: [5]
For the proposed model-based approach, an idealised APTR*
versus pH relationship could also be formed using the relation-
ship above and simulations. By assuming water and amide
proton concentrations of 112 M and 100mM (20), respectively,
and the remaining parameters in the two-pool model (water
and amide) having the mean values in Table 1, saturated by
B1 = 0.55μT and a saturation time of 2 s (to match the experiment),
a range of idealised APTR* versus different pH values [calculated
from Equation [5] by varying the amide proton exchange rates]
could be simulated, and a relationship between them could then
be formed.
For the collected APT data, the idealised APTR* could be calcu-
lated according to Equation [4] using only three parameters from
the model ﬁtting: (1) the ﬁtted unsaturated signal, M0
w; (2) the
ﬁtted amide proton exchange rate, ka–w; and (3) the ﬁtted amide
proton signal, M0
a. As the variations in the remaining parameters
in the ideal one- and two-pool models should have been
accounted for by the ﬁtting algorithm, they were assumed to
have values from the simulations used to generate the idealised
APTR* versus pH relationship. Both ka–w and M0
a were used to cal-
culate the idealised APTR* instead of ka–w, which is related to pH,
because both of these parameters will affect the z-spectrum at
the amide resonance, and it has been proved difﬁcult to separate
their effects in model ﬁtting using a single saturation power
(18,24). M0
w was also included to normalise the measured satu-
rated signal. The idealised APTR* is simply referred to as APTR*
hereafter.
The quantiﬁed APT effects using the different metrics
(MTRasym, MTRasym_comp and APTR*) were transformed to the T1
image space using FLIRT. The T1 structural data were segmented
using FMRIB’s Automated Segmentation Tool (FAST) (31) into
cerebrospinal ﬂuid (CSF), grey and white matter (GM and WM).
Healthy subjects
Two criteria were used to assess the efﬁcacy of the different
quantiﬁcation methods in the healthy control: (1) contrast be-
tween GM and WM in the brain, C = (MGM–MWM)/(MGM+MWM),
where M is the average signal of the studied metrics in a region
of interest (ROI); and (2) CV to study the precision, deﬁned as the
ratio of the standard deviation to the mean of the respective
quantiﬁcation method, in both GM and WM. The most suitable
APT quantiﬁcation method for a healthy brain should produce
the smallest CV in the GM and WM, and have minimum contrast
between these ROIs. In order to minimise partial volume effects
and contamination from non-brain areas, such as CSF, the GM
and WM masks were created using an 80% threshold on the
GM and WM partial volume estimates generated by FAST.
Stroke patients
The DWI data (b=1000 s/mm2) were used to deﬁne the infarct
core, where an infarct core mask for each patient and a mirror
mask of normal tissue in the contralateral hemisphere were manu-
ally drawn by a clinician. The average z-spectra within the infarct
core and contralateral ROIs were plotted to study their differences.
The coefﬁcient of determination, R2, was calculated to assess the
goodness of ﬁt for the model-based analysis in each ROI. Two-
tailed unpaired t-tests were performed comparing the APT effect
between infarct core and the contralateral region using the differ-
ent approaches to examine which metric was more suitable to dis-
tinguish the two tissue types. The t-tests were performed twice for
MTRasym and MTRasym_comp; once directly on the calculated values
(unbounded) and once within a speciﬁed range (bounded): 0.05
MTRasym< 0;0.5<MTRasym_comp< 0. This was done tominimise
Figure 1. Measured z-spectra after B0 correction and model ﬁts in the different regions of interest of Patients 3 (top row) and 5 (bottom row). The red
areas indicate the infarct core [hyperintensity on diffusion-weighted imaging (DWI) data (b=1000 s/mm2) acquired during admission] and the blue re-
gions show the contralateral normal-appearing tissue. Very good ﬁts were obtained in the regions of interest with the coefﬁcient of determinant
R2≥ 98.6%. The vertical black dashed lines represent the chemical shift of amide protons and the blue/red dashed lines underneath the ﬁts and mea-
sured data are the residuals.
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the inﬂuence of measurement noise and artefacts, such as imper-
fect fat suppression.
The contrast-to-noise ratio (CNR), deﬁned as CNR=
C/CVContralateral, where C is the contrast between the infarct core
and contralateral normal-appearing tissue and CVContralateral
refers to CV in the contralateral tissue, was calculated to assess
which APT quantiﬁcation method was most suitable for clinical
stroke imaging.
RESULTS
The representative z-spectra and model-based ﬁts in the infarct
core (hyperintensity on the DWI data acquired during admission)
and the contralateral normal-appearing tissue of Patients 3 and 5
are plotted in Fig. 1. From the measured data, all the z-spectra in
the infarct core were found to have a higher magnitude of
magnetisation ratio (smaller saturation effect) at the chemical
shift of amide protons when compared with the contralateral
ROI (Figs 1 and S1). Very good ﬁts were obtained using the
three-pool model, where R2≥ 98.6% in the ischaemic and contra-
lateral ROIs. The main discrepancy between the ﬁts and mea-
sured data was found to be around the water centre frequency.
The quantiﬁed APT effects in the healthy volunteers using the
different metrics are shown in Fig. 2. There were some intra- and
inter-subject variations in the quantiﬁed APT effect using the dif-
ferent methods in GM and WM, but no obvious low signal areas
were observed. The mean, standard deviation and CV of GM and
WM, together with the contrast from each metric, are presented
in the bottom row of Fig. 2. The APT effect was found to be neg-
ative when asymmetry measures (MTRasym and MTRasym_comp)
were used, with the APT effect in WM more negative than in
GM. When the APT effect was quantiﬁed using APTR*, positive
differences were obtained; WM had a consistently smaller APTR*
magnitude than GM. APTR* was found to have the smallest CV in
GM and WM (≤13.8%), and also the smallest average contrast be-
tween these tissue types (Cavg = 3.48%). MTRasym had the highest
contrast between GM and WM, but a smaller CV than
MTRasym_comp, in each region.
Figure 3 shows the DWI data and the calculated APT effect
using MTRasym, MTRasym_comp and APTR* for representative
Patients 3 and 5. In Patient 3 (top row of Fig. 3), APTR* and
MTRasym_comp showed a low signal area in the infarct core
identiﬁed from the area of hyperintensity in the DWI image
(b= 1000 s/mm2). In the MTRasym image of this patient, the differ-
ence between ischaemic and healthy tissue was less obvious
when compared with the other two metrics. Results from Patient
5 are shown in the bottom row of Fig. 3; it was observed that all
three metrics showed a different degree of signal reduction in
the infarct core. The low signal areas of APTR* and MTRasym_comp
were slightly larger than the area of hyperintensity in the
DWI image.
Figure 2. Amide proton transfer (APT) reference images and calculated maps of APTR*, MTRasym and MTRasym_comp of healthy volunteers. Tissue masks
were used to remove the non-tissue areas, such as cerebrospinal ﬂuid (CSF); thus, the scale bar does not reﬂect the quantiﬁed APT effect in these areas.
The bar graphs and error bars are the means and standard deviations, respectively, of each metric in the grey matter (GM) and white matter (WM). CV
stands for coefﬁcient of variation and C refers to the contrast between GM and WM.
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The means and standard deviations of each metric in the in-
farct core and contralateral normal-appearing tissue area of each
patient are shown in Fig. 4, together with the results of the
t-tests. Signiﬁcant differences between APTR* in the infarct core
and contralateral tissue were found for all patients (p< 0.001,
labelled ‘**’ in Fig. 4a), except Patient 6. The calculated APTR*
was consistently lower in the infarct core than in the contralat-
eral normal-appearing tissue, with the group means and stan-
dard deviations equalling 0.015 ± 0.0031 and 0.019 ± 0.0037,
respectively. When the unbounded MTRasym and MTRasym_comp
in these regions were compared using t-tests (Fig. 4b, c), some
of the results showed signiﬁcant differences, but large standard
deviations were observed, for example, MTRasym_comp in Patients
1 and 2. When the bounded MTRasym and MTRasym_comp between
the infarct core and contralateral normal-appearing tissue were
analysed, signiﬁcant differences between these two regions
were found for all patients (labelled ‘*’ for p< 0.05 and ‘**’ for
p< 0.001 in Fig. 4d, e), except for MTRasym and MTRasym_comp in
Patient 6. The quantiﬁed APT effect using the asymmetry mea-
sures (MTRasym and MTRasym_comp) showed a more negative sig-
nal in the infarct core when compared with the contralateral
tissue in all cases, except for MTRasym in Patient 6. The group
means and standard deviations of MTRasym were
0.013 ± 0.0058 in the contralateral region and 0.015 ± 0.0072
in the infarct core. For MTRasym_comp, the group results were
0.157 ± 0.068 in the contralateral region and 0.212 ± 0.091
in the infarct core. There were inter-subject variations for all
the metrics investigated in either of the ROIs.
Table 2 shows the contrast between the infarct core and con-
tralateral normal-appearing tissue and the calculated CV in the
contralateral tissue for all patients; for the asymmetry analyses
(MTRasym and MTRasym_comp), only the bounded results are
Figure 3. Diffusion-weighted imaging (DWI) (b=1000 s/mm2) and processed amide proton transfer (APT) results (APTR*, MTRasym and MTRasym_comp)
from representative patients: top row, Patient 3; bottom row, Patient 5. Tissue masks were used to remove the non-tissue areas, such as cerebrospinal
ﬂuid (CSF); thus, the scale bar does not reﬂect the quantiﬁed APT effect in these areas.
Figure 4. Results of unpaired t-tests between the infarct core and contralateral normal-appearing tissue region of APTR*, MTRasym and MTRasym_comp,
where the signiﬁcant differences are labelled as: *p< 0.05; **p< 0.001. The ‘Group’ label represents the average results of all patients. The bar graphs
and error bars refer to the means and standard deviations of each metric, respectively. Bounded results (d and e) include only MTRasym within 0 and
0.05, and MTRasym_comp within 0.5 and 0, whereas the unbounded results (b and c) include all the calculated values.
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included. Although the overall contrast of APTR* for all the pa-
tients was not as high as for the other two metrics, it was able
to quantify the contralateral APT effect with smaller variation.
Thus, APTR* was able to produce the highest CNR, followed by
MTRasym_comp and MTRasym.
Previously, a logarithmic relationship between the intracellular
pH and amide proton exchange rate has been derived using
both phosphorus and water exchange spectroscopy (5) (Fig. 5,
top left). Using this logarithmic relationship and assuming that
the model parameters in water and amide pools had the mean
values in Table 1, a further relationship between pH and APTR*
was formed, where pH=1.951 × (APTR*)0.2444 + 4.807 (Fig. 5, top
right). Based on the pH and APTR* relationship formed, quantita-
tive pH maps of the healthy volunteers and patients were pro-
duced, as shown in Fig. 5. Relatively homogeneous pH maps
were obtained for the healthy subjects, with tissue having pH
values of 7.04 ± 0.07. The pH colour bar was set according to
ref. (5), where 7.11 ± 0.13 is normal (green) and below 6.9 is isch-
aemic (pink to red), which effectively thresholds the results. In
representative patient cases, lower pH values (Fig. 5, blue lined
areas, pH= 6.94 ± 0.14) were noticeable in the infarct core, as
identiﬁed by a clinician based on hyperintensity on the DWI data
at admission. Lower pH values were also observed around the
edge of the brain and tissue areas proximal to CSF in patient
data, as well as in healthy subjects, but to a much smaller extent
when compared with the former.
DISCUSSION
This study examined different ways of quantifying the APT effect
on data acquired in patients with hyperacute stroke: MTRasym,
MTRasym_comp and APTR*. From the results, APTR* was able to
generate the smallest contrast between GM and WM, and CV
in the healthy subjects, which is desirable. All the quantiﬁcation
methods showed a more elevated APT effect in GM than WM
(Fig. 2), which has been observed previously by others
(18,21,32,33). This most probably relates to differences in labile
proton concentrations and is something that none of the
methods considered here can truly control for.
When APTR* was applied to quantify the APT effect in the data
from patients with hyperacute stroke, the quantiﬁed effects were
consistently lower in the infarct core relative to the contralateral
normal-appearing tissue for all patients, and statistically signiﬁ-
cant differences at a 5% signiﬁcance level were found between
these tissue regions for all patients, except Patient 6. Without
setting a proper bound for the statistical analyses, MTRasym and
MTRasym_comp were found to have large variations within the
ROIs. These asymmetry measures appear to be more susceptible
than the model-based analysis to noise and artefacts. MTRasym
and MTRasym_comp were found to be mostly negative, unlike
APTR*, this being observed previously (18,32) when relatively
low RF saturation powers are employed. Thus, any pH estimation
based on the asymmetry measures would be more strongly
inﬂuenced by the aliphatic signal (negative offsets), conﬂicting
with its intended use as a metric to describe the APT effect.
Nevertheless, the asymmetry analysis method did demonstrate
the ability to identify apparent APT effects. Since they can be cal-
culated more quickly than the model-based approach, they re-
main suitable as a ﬁrst approximation and as a means of
generating non-quantitative contrast images.
APT experiments are commonly performed using a higher
saturation power than that used in this study to maximise the
contrast and to generate a positive difference when asymmetry
analysis is used to quantify the effect. However, a high power
contributes to large MTC and spillover effects (33), making the
use of asymmetry analysis less speciﬁc to the APT effect alone.
Based on efﬁciency theory (12,21), only a small power is required
to fully saturate the protons that are in slow exchange with the
water protons, such as amide, at approximately 28 Hz (5). There-
fore, the APT experiments in this study were performed using a
small irradiation power to minimise the contamination from
other transfer of magnetisation effects. However, the difference
in the irradiation power used may have inﬂuenced the efﬁcacy
of the asymmetry measures here.
In order to speed up the model-based analysis, the average
power of the Gaussian pulses was used instead of a discretisation
method which segments each pulse into n intervals; the ﬁnal
magnetisation is achieved by propagating the calculation through
all the intervals, with the calculated signals at one segment used as
the initial conditions for the following one. As a result of this simpli-
ﬁcation, the model ﬁtting was not able to ﬁt the signal well around
the water centre frequency (Fig. 1) because of the difference in the
bandwidth between the irradiation scheme used and that
assumed in the model; a continuous irradiation scheme is able to
saturate the pool more efﬁciently, leading to narrower off-
resonance excitation when compared with the pulsed saturation
used in this study. One of the main reasons for using the continu-
ous approximation, even though it affects the model ﬁtting, is to
make the quantiﬁcation method more clinically relevant in term
Table 2. Contrast (C) between infarct core and contralateral
normal-appearing tissue, and coefﬁcient of variation (CV) in
the contralateral tissue of APTR*, MTRasym and MTRasym_comp
of each patient. All the results are expressed in absolute per-
centage values (%); only bounded MTRasym and MTRasym_comp
are included
Patient C CVContralateral CNR= C/CVContralateral
APTR*
1 4.01 14.2 28.24
2 5.15 15.2 33.88
3 9.31 16.1 57.83
4 16.16 25.0 64.64
5 12.09 14.7 82.24
6 2.27 13.9 16.33
Average 47.19
MTRasym
1 20.26 64.6 31.36
2 20.00 54.1 36.97
3 2.54 33.4 7.60
4 7.74 57.6 13.44
5 10.61 28.6 37.10
6 2.53 31.0 8.16
Average 22.44
MTRasym_comp
1 23.50 65.9 35.66
2 22.48 50.4 44.60
3 9.46 32.5 29.11
4 22.62 58.4 38.73
5 11.58 25.9 44.71
6 2.30 27.6 8.33
Average 33.52
CNR, contrast-to-noise ratio.
QUANTIFICATION OF MRI APT EFFECT IN PATIENTS WITH HYPERACUTE STROKE
NMR Biomed. 2014; 27: 1019–1029 © 2014 The Authors. NMR in Biomedicine published by
John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/nbm
1025
of processing time. The APTR* and pH information can be gener-
ated in less than 10min on a normal PC with eight cores of proces-
sors by processing the APT data in parallel. The ﬁtting accuracy
around the water centre frequency can be improved using the
computationally expensive discretisation method (23). Neverthe-
less, the differences between the important ﬁtted parameters,
such as the amide proton exchange rate, using the continuous
approximation and discretisation method, for protons with a slow
exchange rate, should be small; thus, this should not signiﬁcantly
affect the APTR* results here (23).
When the average z-spectra across a ROI in the ischaemic and
contralateral tissue of patients were analysed, the APT effect was
observed to decrease in the infarct core, as was the signal in the
aliphatic range, when compared with the contralateral side, for
some of the patients, as shown in Fig. 1. The change at
3.5 ppm has been attributed to acidosis, which leads to a slower
amide proton exchange rate and thus a smaller APT effect (5).
The post-stroke effect in the aliphatic range has not been widely
reported. A previous study in a preclinical model has suggested
that the saturation effect at the negative offsets is pH insensitive
(34), whereas the recent literature on phantoms has shown that
the effect is pH dependent (17) under low-power saturation,
such as the study presented here. This discrepancy may arise
from the different RF irradiation powers used, because NOE has
been shown to be power dependent (35). The change at the
negative frequency offsets is not surprising because the brain
undergoes cascaded and complex physiological adaptation after
ischaemic injury. These adaptations have been reported
previously by many spectroscopy studies, including noticeable
changes in the aliphatic range during severe energy failure (36)
and an increase in neutral lipid droplets in the infarcted region
following induced stroke (37).
Using the relationship of pH and APTR* found from the
simulation, quantitative pH maps were demonstrated in healthy
subjects and in patients with hyperacute stroke. When the
proposed method was applied to the healthy volunteers, rela-
tively homogeneous pH maps were obtained, which is expected,
reﬂecting the assumption that APT provides a direct measure of
pH because the body will try to maintain homeostasis. In
patients, lower pH values were observed in the ischaemic area,
Figure 5. Top left: a logarithmic relationship between pH and amide proton exchange rate proposed by ref. (5). Top right: the pH versus APTR* rela-
tionship formed by simulations; very good ﬁts were obtained (R2 = 99.94%) for pH 6.4–7.5. The middle and bottom rows show the quantitative pH maps
of healthy subjects and patients illustrated in Figs 2 and 3, respectively, generated using the pH and APTR* relationships found. The pH scale is set
based on the logarithmic relationship study (5), where pH7.11 ± 0.13 is normal (green) and below pH6.9 is ischaemic (pink to red), which effectively
thresholds the results. The blue lines in the patient images represent the area of the infarct core deﬁned on the basis of the diffusion-weighted imaging
(DWI) data. Tissue masks were used to remove the non-tissue areas, such as cerebrospinal ﬂuid (CSF); thus, the colour scale does not reﬂect the quan-
tiﬁed amide proton transfer (APT) effect in these areas.
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as shown in Fig. 5. To the best of our knowledge, these are the
ﬁrst quantitative pH maps generated from APT imaging in
hyperacute stroke patients. The relationship used here is speciﬁc
to the saturation scheme employed, although the methodology
could be employed to generate a similar relationship for other
schemes. Ideally, only the exchange rate constant would be
extracted from the model-based analysis and used to calculate
pH, but it remains difﬁcult to separate the effects of exchange
rate and proton concentration from a sampled z-spectra (18,24).
Although realistic pH maps were generated in this study,
artefacts (low pH values) were seen in the non-ischaemic tissue
areas, a problem that was particularly noticeable in the patient
cohort. There are several factors that might explain this. First,
Equation [5] was derived using phosphorus spectroscopy,
which primarily assesses the intracellular pH, and by assuming
that phosphate species experience the same intracellular
environment as amide protons (5); this remains to be validated.
Second, the derived relationship [Equation [5]] has been found
to show some discrepancies in relation to an APT study carried
out by a different centre (9). The discrepancies have been
suggested to be a result of the calibrated MTRasym versus pH
relationship, which may not be the same at different centres
because the imaging technique is not standardised (16) and
MTRasym is dependent on the acquisition method. Furthermore,
as MTRasym does not contain the APT effect alone, recalibration
may be necessary to form a more accurate relationship
between pH and APTR*, as the latter can quantify the pure
APT effect by removing all the other contaminating effects
using the model-based analysis. Finally, the concentration of
amide protons was set to be 100mM across the brain in the
simulations to generate the pH and APTR* relationship. This is
probably the main factor contributing to the artefacts seen on
the generated pH maps, aside from the motion artefacts,
because there is zero or minimal endogenous mobile protein
and peptide concentration in non-tissue areas, such as the
CSF. The partial volumes of these low or no amide concentra-
tion regions within the tissue area may cause the model to
estimate them as having a low APT effect. This effect is
likely to be more pronounced in the older patients observed
here compared with the younger healthy subjects because of
atrophy. The low APT effect caused by partial volume
contamination has also been reported by others using MTRasym
(10), suggesting that a better post-processing partial volume
correction technique may be required, because the APT slice
is normally thicker than the T1 structural image used for
segmentation.
The published literature on the application of APT imaging in
patients with stroke to date has a mean onset time of hours (4)
to 4.3 days (10) after the onset of ischaemia. Even though some
of the patients were scanned in the delay phase (days after
onset), the APT effect quantiﬁed using MTRasym still showed a
lower signal in the ‘ischaemic’ area when compared with the
contralateral normal-appearing tissue. However, the quantiﬁed
signal may not reﬂect the pH effect alone, because the initial
assumptions regarding the negligible change in water relaxation
time and proton concentration may well not hold at this stage of
stroke evolution. Oedema formation and inﬂammation are
common secondary phenomena after stroke that can alter the
magnetic properties of water. There may also be a change
in the amide proton concentration as a result of changes in
protein synthesis and degradation, and the loss of cytoplasm,
days after onset. In addition, a change in the diffusivity in the
ischaemic area could possibly affect the exchange rate between
water and amide protons. As a result, various other MRI
acquisitions are required to account for all of these variations,
such as the methods used in a previous preclinical study (6) in
order to quantify the APT effect using asymmetry analysis.
However, these extra scans will increase the patient scan time
and are thus not practical in the setting of acute stroke,
supporting the use of model-based analysis, which can account
for all of these variations.
It should be noted that a number of assumptions were made
when calculating APTR* and converting it to quantitative pH in-
formation. When performing the model ﬁtting, only three pools
were considered; the possible contributions from other labile
protons, such as amine and hydroxyl protons, to the APT effect
were assumed to be minimal, as a low saturation power was
used in this study. In the third pool, it was assumed that MTC
and NOE could be represented as a single pool, which has been
done previously in the literature (18,27). However, combining
these two transfer mechanisms might oversimplify the in vivo
environment, and there is a possibility that, with a model-driven
analysis, the combined MT and NOE pool implemented here
might be suboptimal, and this could in turn affect the B0
estimation. One of the possible solutions is to exclude the
NOE data and only ﬁt the measured signal around amide
and water pools using a three-pool model, where the third
pool models only the MTC effect. There is certainly scope to
investigate this issue further, especially if NOE is to be used
to assess ischaemic injury.
Based on a previous study (5), we assumed that there was
negligible change in the water relaxation parameters during
early stroke onset. By doing so, a simple APTR* versus pH rela-
tionship could be formed; it may be necessary to account more
fully for changes in relaxation parameters in ischaemic tissue.
Although multiple assumptions were made when quantifying
the APT effect using the proposed model-based approach, the
results obtained in the healthy subjects and patients clearly
showed that the quantiﬁed APT effect in the ischaemic tissue
was smaller than in the normal tissue, consistent with the acidi-
ﬁcation theory and the reported APT effect after stroke in both
preclinical and clinical studies.
As saturation was performed using Gaussian pulses with
a ﬂip angle close to 180°, it is likely that there will be some
chemical exchange rotation transfer (CERT)-related effects
(present when γB1 ≥ labile proton exchange rate, where γ is
the gyromagnetic ratio) (38). For the average power (0.55 μT)
used in this study, the CERT-related effects would be observed
when the exchange rate was below 23.4 Hz. The amide proton
exchange rate is expected to be 28 Hz (5) in normal tissue.
When stroke occurs, the change in the measured signal at
3.5 ppm implies a slowing of the amide proton exchange rate;
thus, it is likely that the CERT-related effects would exist in
the ischaemic tissue.
Finally, it should also be noted that other methods exist to
quantify the APT effect, such as Lorentzian difference analysis
(21) and a three offset measurement approach (34), but these
methods were not considered in this study. Although they are
less contaminated by effects, such as NOE, these approaches
are still not able to account for all the variations discussed above.
In addition, the three offset measurement technique requires the
APT effect to be present as a well-deﬁned dip on the z-spectra,
which is not generally achievable when the acquisition is
performed at 3 T.
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CONCLUSIONS
In this study, different APT quantiﬁcation methods were assessed
on data acquired from healthy volunteers and hyperacute stroke
patients. Clear changes in the APT signal in patients within the
region of ischaemia, as identiﬁed from DWI, were observed using
all the quantiﬁcation methods. It was found that the model-
based approach was more robust and performed better at quan-
tifying the APT effect than the widely used asymmetry measures,
such as MTRasym, on both the healthy volunteer and patient APT
data for the acquisition settings used. Results from the model-
based analysis were employed to generate quantitative pH maps
using published calibration data; relatively homogeneous pH
maps were obtained in healthy subjects, and lower pH values
were seen in the ischaemic tissue of patients with hyperacute
stroke.
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